Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Q3 Revenues Up Amid Narrowed Net Loss

NEW YORK, Nov. 4 (GenomeWeb News) - Cepheid today reported a slight year-over-year increase in third-quarter revenues amid narrowed net losses.

 

The Sunnyvale, Calif., instrument and reagent company had revenues of $5.4 million for the third quarter, compared to $4.4 million for the third quarter of 2002.  Net loss narrowed to $3.9 million, from $5.8 million for the same period last year.

 

The company's R&D expenses totaled $4.0 million, compared to $4.5 million in the same period of last year.

 

As of September 30, Cepheid had $15.2 million in cash and cash equivalents.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.